 | Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT - GlobeNewswire
globenewswire.com - July 29 at 5:33 PM |
 | Cellectis organise une conférence téléphonique pour présenter ses résultats financiers du deuxième trimestre 2021 le vendredi 6 août à 14h00 CET
finance.yahoo.com - July 29 at 5:33 PM |
| Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT
finance.yahoo.com - July 29 at 5:33 PM |
 | Metagenomi Appoints Simon Harnest as Chief Investment Officer - StreetInsider.com
streetinsider.com - July 29 at 7:32 AM |
| Metagenomi Appoints Simon Harnest as Chief Investment Officer - Yahoo Finance
finance.yahoo.com - July 28 at 2:51 PM |
 | Metagenomi Appoints Simon Harnest as Chief Investment Officer - Business Wire
businesswire.com - July 28 at 9:49 AM |
 | Cellectis S.A. (NASDAQ:CLLS) Given Average Recommendation of "Buy" by Brokerages
americanbankingnews.com - July 28 at 1:26 AM |
| Cellectis (NASDAQ:CLLS) Sets New 52-Week Low at $13.07
americanbankingnews.com - July 26 at 12:43 PM |
|
| Cellectis (NASDAQ:CLLS) Shares Gap Up to $13.85
americanbankingnews.com - July 23 at 10:28 AM |
| Cellectis (NASDAQ:CLLS) Sets New 1-Year Low at $13.44
americanbankingnews.com - July 15 at 12:43 PM |
 | Cellectis Offers An Idiosyncratic Risk Profile With Remarkable Upside Potential - Seeking Alpha
seekingalpha.com - July 13 at 10:30 PM |
| Zacks: Brokerages Anticipate Cellectis S.A. (NASDAQ:CLLS) Will Post Quarterly Sales of $12.43 Million
americanbankingnews.com - July 12 at 2:28 AM |
| Zacks: Brokerages Expect Cellectis S.A. (NASDAQ:CLLS) to Post -$0.75 EPS
americanbankingnews.com - July 10 at 3:16 PM |
| Cellectis (NASDAQ:CLLS) Sees Large Volume Increase
americanbankingnews.com - July 9 at 11:57 AM |
 | 2 “Strong Buy” Stocks Flirting With a Bottom - Nasdaq
nasdaq.com - July 9 at 1:09 AM |
| 2 “Strong Buy” Stocks Flirting With a Bottom
finance.yahoo.com - July 8 at 8:09 PM |
| Cellectis (NASDAQ:CLLS) Reaches New 12-Month Low at $14.18
americanbankingnews.com - July 7 at 11:54 AM |
| The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the Century - Nasdaq
nasdaq.com - July 3 at 9:57 AM |
| Allogene (ALLO) Multiple Myeloma Candidate Gets Fast Track Tag - Nasdaq
nasdaq.com - July 1 at 7:38 PM |
| CRISPR: 4 Emerging Players - Seeking Alpha
seekingalpha.com - June 30 at 1:40 PM |
| Global Gene Therapy Markets Report 2021-2030: Antigen, Cytokine, Suicide Gene, Viral Vector, Non-Viral Vector, Oncological, Rare Diseases, Cardiovascular, Neurological Disorders, Infectious Diseases - Yahoo Finance
finance.yahoo.com - June 25 at 7:47 AM |
| Gene Therapy Global Market Report 2021: COVID-19 Impacts, Growth and Changes to 2030 - ResearchAndMarkets.com - Business Wire
businesswire.com - June 24 at 12:51 PM |
| Cellectis: FYE 2021 TALEN CAR-T Data Announcement Should Catalyse Strong Upside - Seeking Alpha
seekingalpha.com - June 22 at 5:41 PM |
| Olivier Gouédard, PharmD, MBA joins Cytovia Therapeutics as Chief Operating Officer - StreetInsider.com
streetinsider.com - June 22 at 12:41 PM |
| William Sullivan, CPA, MBA joins Cytovia Therapeutics as Chief Financial Officer - StreetInsider.com
streetinsider.com - June 15 at 5:44 PM |
| Cellectis Unveils Four Additional Preclinical Candidates For Solid Tumors - Yahoo Finance
finance.yahoo.com - June 15 at 5:44 PM |
|
 | Cellectis Unveils Four Additional Preclinical Candidates For Solid Tumors - Benzinga
benzinga.com - June 15 at 12:43 PM |
| Cellectis Unveils Four Additional Preclinical Candidates For Solid Tumors
finance.yahoo.com - June 15 at 12:43 PM |
| StrideBio Expands Leadership Team with Accomplished Industry Executives - StreetInsider.com
streetinsider.com - June 15 at 7:43 AM |
| Cellectis outlines four new UCART preclinical programs; reveals .HEAL, a genome surgery platform - Seeking Alpha
seekingalpha.com - June 15 at 7:43 AM |
| Cellectis' Innovation Days event highlighted New Product - GlobeNewswire
globenewswire.com - June 14 at 8:02 PM |
| Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities
finance.yahoo.com - June 14 at 8:02 PM |
| Gecina Pre-lets the Biopark Building in Paris' 13th Arrondissement - StreetInsider.com
streetinsider.com - June 9 at 7:53 PM |
| Gecina Pre-lets the Biopark Building in Paris' 13th Arrondissement - Business Wire
businesswire.com - June 9 at 2:53 PM |
| Cellectis SA Stock Gives Every Indication Of Being Possible Value Trap - Yahoo Finance
finance.yahoo.com - June 5 at 9:24 AM |
| Allogene Therapeutics Presents Positive Phase 1 Data on ALLO-501 and ALLO-501A in Relapsed/Refractory Non-Hodgkin Lymphoma at the 2021 Annual Meeting of the American Society of Clinical Oncology - StreetInsider.com
streetinsider.com - June 4 at 1:27 PM |
| Cellectis SA Reports Results from Annual Shareholders' - GlobeNewswire
globenewswire.com - June 2 at 10:04 AM |
| Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021
finance.yahoo.com - June 2 at 10:04 AM |
| Allogene Therapeutics CD19 Forum Highlights Positive Results from Phase 1 Studies of ALLO-501 and ALLO-501A in Relapsed/Refractory Non-Hodgkin Lymphoma and Plan to Initiate Pivotal Study in 2021 - StreetInsider.com
streetinsider.com - May 19 at 7:45 PM |
| Global Stem Cell Therapy Market Report 2021-2030: Allogeneic Stem Cell & Therapy Autologous Stem Cell Therapy / Adult Stem Cells, Induced Pluripotent Stem Cells, & Embryonic Stem Cells - Yahoo Finance Australia
finance.yahoo.com - May 19 at 9:26 AM |
| Global Stem Cell Therapy Market Report 2021-2030 Featuring Anterogen, JCR Pharma, Medipost, Osiris Therapeutics, Pharmicell, Astellas Pharma, Cellectis, Celyad, Novadip Biosciences, and Gamida Cell - Yahoo Finance
finance.yahoo.com - May 17 at 2:07 PM |
| Cytovia Therapeutics CEO Dr. Daniel Teper to Present at Two Upcoming Conferences - Yahoo Finance
finance.yahoo.com - May 14 at 1:36 PM |
| Global Stem Cell Therapy Market Report 2021: COVID-19 Influences, Growth and Changes to 2030 - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - May 14 at 8:36 AM |
| Allogene Therapeutics to Host Virtual CD19 Forum on May 19, 2021 - StreetInsider.com
streetinsider.com - May 13 at 1:31 AM |
| Health Care Sector Update for 05/12/2021: INO, SIEN, CLLS, SNY, XLV, IBB - Nasdaq
nasdaq.com - May 12 at 8:30 PM |
| Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T - GlobeNewswire
globenewswire.com - May 11 at 6:12 PM |
| Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
finance.yahoo.com - May 11 at 6:12 PM |
| Cellectis EPS beats by $0.52, beats on revenue - Seeking Alpha
seekingalpha.com - May 7 at 3:12 AM |
| India's COVID-19 cases soar with over 412,000 confirmed - Yahoo Canada Finance
ca.finance.yahoo.com - May 6 at 5:11 PM |
| Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021 - GlobeNewswire
globenewswire.com - May 6 at 5:11 PM |
